000			01582 a2200409 4500
005			20250513035445.0
264		0	_c19951004
008			199510s 0 0 eng d
022			_a0899-823X
024	7		_a10.1086/647120 _2doi
040			_aNLM _beng _cNLM
100	1		_aBryce, E A
245	0	0	_aFocused microbiological surveillance and gram-negative beta-lactamase--mediated resistance in an intensive care unit. _h[electronic resource]
260			_bInfection control and hospital epidemiology _cJun 1995
300			_a331-4 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aBacterial Typing Techniques
650	0	4	_aBritish Columbia
650	0	4	_aCross Infection _xepidemiology
650	0	4	_aDisease Outbreaks
650	0	4	_aDrug Resistance, Multiple
650	0	4	_aGram-Negative Bacteria _xclassification
650	0	4	_aGram-Negative Bacterial Infections _xdrug therapy
650	0	4	_aHospital Bed Capacity, 500 and over
650	0	4	_aHumans
650	0	4	_aIntensive Care Units
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aPopulation Surveillance
650	0	4	_aPseudomonas Infections _xepidemiology
650	0	4	_aPseudomonas aeruginosa _xdrug effects
650	0	4	_abeta-Lactam Resistance
700	1		_aSmith, J A
773	0		_tInfection control and hospital epidemiology _gvol. 16 _gno. 6 _gp. 331-4
856	4	0	_uhttps://doi.org/10.1086/647120 _zAvailable from publisher's website
999			_c7657415 _d7657415